HUTCHMED's Experimental Drug Shows Durable Responses In Advanced Bile Duct Cancer Trial - HUTCHMED (China

HUTCHMED reported positive Phase 2 data for fanregratinib in advanced ICC as China reviews the drug.

Raccontata dabenzinga.com